CP17 Working in Industry: Antibody Drug Conjugates - Process Chemistry in Action

New

If you have an interest in becoming a process chemist, this session will be of interest to you. Antibody Drug Conjugates (ADCs) represent an exciting new class of therapeutics, combining a tumour targeting antibody with a cell-killing cytotoxic drug (Payload). Payloads are typically highly complex natural products prepared using lengthy and challenging synthetic routes. This talk provides background on ADCs and the types of payloads used in these molecule, then focusses on the Process Chemistry work completed on the development and scale-up of AstraZeneca’s Tubulysin payloads.

Number of sessions: 1